scispace - formally typeset
S

Shigehiro Katayama

Researcher at Saitama Medical University

Publications -  251
Citations -  11344

Shigehiro Katayama is an academic researcher from Saitama Medical University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 49, co-authored 251 publications receiving 10637 citations.

Papers
More filters
Journal ArticleDOI

Effects of the Activation of Three Major Hepatic Akt Substrates on Glucose Metabolism in Male Mice.

TL;DR: FoxO1 has the most prominent role in transducing insulin's effect downstream from Akt to suppress hepatic glucose output, involving mechanisms independent of the transcriptional regulation of key gluconeogenic enzymes.
Journal Article

Japan Diabetes Complications Study (JDCS)

TL;DR: Differences between Japanese and Caucasian patients with type 2 diabetes demonstrate the necessity of obtaining clinical evidence based on large-scale studies of Japanese patients in order to provide management and care specific to this population.
Journal ArticleDOI

Preclinical Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia with excessive secretion of 18-hydroxydeoxycorticosterone and corticosterone.

TL;DR: Hormonal findings would support the hypothesis that the tumor of AIMAH originated from cells of the upper zona fasciculata, and respond to ACTH and was increased by hypoglycemia without modifying ACTH levels.
Journal ArticleDOI

Hypercalcemia Accompanied by Hypothalamic Hypopituitarism, Central Diabetes Inspidus and Hyperthyroidism

TL;DR: In the present case, concurrent hyperthyroidism was assumed to accelerate skeletal mobilization of calcium into the circulation through renal handling of Ca and Hypocortisolism and central DI was also considered to contribute, to some extent, to the hypercalcemia.
Journal ArticleDOI

Proposed Reference Material for Human Free Immunoglobulin Light Chain Measurement

TL;DR: In this article, the authors purify intact free immunoglobulin light chain (FLC) kappa and lambda from the pooled urine specimens of healthy volunteers as the first reference materials for FLC assays.